1 |
Alqahtani A, Khan Z, Alloghbi A, et al. Hepatocellular carcinoma: Molecular mechanisms and targeted therapies[J]. Medicina, 2019, 526(9):526.
|
2 |
田大治, 张炜琪, 蒋文涛. 肝癌分子靶向治疗的现状与展望[J]. 国际生物医学工程杂志, 2020, 43(5):400-405.
|
3 |
马晓琨, 夏伟. 微小RNAs在肝癌中的作用机制及相关应用研究进展[J/OL]. 中华细胞与干细胞杂志(电子版), 2020, 10(1):58-62.
|
4 |
Hui X, Hu YW, Zhao JY, et al. MicroRNA-195-5p acts as an anti-oncogene by targeting PHF19 in hepatocellular carcinoma[J]. Oncol Rep, 2015, 34(1):175-182.
|
5 |
Liu LX, Liu B,Yu J, et al. SP1-induced upregulation of lncRNA CTBP1-AS2 accelerates the hepatocellular carcinoma tumorigenesis through targeting CEP55 via sponging miR-195-5p[J]. Biochem Biophys Res Commun, 2020, 533(4):779-785.
|
6 |
Li J, Sun D, Pu W, et al. Circular RNAs in cancer: Biogenesis, function, and clinical significance[J]. Trends Cancer, 2020, 6(4):319-336.
|
7 |
Huang Q, Guo H, Wang S, et al. A novel circular RNA, circXPO1, promotes lung adenocarcinoma progression by interacting with IGF2BP1[J]. Cell Death Dis, 2020, 11(12):1031.
|
8 |
Wang T, Zhang Q, Wang N, et al. Research progresses of targeted therapy and immunotherapy for hepatocellular carcinoma [J]. Curr Med Chem, 2021, 28(16):3107-3146.
|
9 |
李建基, 杨哲, 黄赞松. 原发性肝癌分子靶向治疗基础与临床研究进展[J]. 世界华人消化杂志, 2019, 27(10):49-56.
|
10 |
李克跃,魏国微,黎涛,等. 肝癌肝移植手术前后靶向及免疫治疗的指征及时机探讨 [J]. 器官移植, 2022, 13 (5): 561-568.
|
11 |
宋秀道, 马锦. 基于生物信息学分析miRNA-195-5p在肝癌中的表达及其临床意义[J]. 生命科学研究, 2019, 23(2):100-107.
|
12 |
Huang D, Wei Y, Zhu J, et al. Long non-coding RNA SNHG1 functions as a competitive endogenous RNA to regulate PDCD4 expression by sponging miR-195-5p in hepatocellular carcinoma[J]. Gene, 2019, 714:143994.
|
13 |
Bu L, Tian Y, Wen H, et al. miR-195-5p exerts tumor-suppressive functions in human lung cancer cells through targeting TrxR2[J]. Acta Biochim Biophys Sin, 2020, 53(2):189-200.
|
14 |
Huang G, Liang M, Liu H, et al. CircRNA hsa_circRNA_104348 promotes hepatocellular carcinoma progression through modulating miR-187-3p/RTKN2 axis and activating Wnt/β-catenin pathway[J]. Cell Death Dis, 2020, 11(12):1065.
|
15 |
Zhou XY, Yang H, Bai YQ, et al. hsa_circ_0006916 promotes hepatocellular carcinoma progression by activating the miR-337-3p/STAT3 axis[J]. Cell Mol Biol Lett, 2020, 25(1):47.
|
16 |
Jiang Y, Hou J, Zhang X, et al. Circ-XPO1 upregulates XPO1 expression by sponging multiple miRNAs to facilitate osteosarcoma cell progression[J]. Exp Mol Pathol, 2020, 117(6):104553.
|
17 |
Wang X, Wang J, An Z, et al. CircXPO1 promotes glioblastoma malignancy by sponging miR-7-5p[J]. Cells, 2023, 12(6):831.
|
18 |
Chen H, Zhang P, Yu B, et al. The Circular RNA circXPO1 promotes tumor growth via sponging microRNA-23a in prostate carcinoma[J]. Front Oncol, 2021, 11:712145.
|
19 |
Zhu ZY, Tang N, Wang MF, et al. Comprehensive pan-cancer genomic analysis reveals PHF19 as a carcinogenic indicator related to immune infiltration and prognosis of hepatocellular carcinoma[J]. Front Immunol, 2022, 12:781087.
|
20 |
Niu J, Wang Y, Hu Y, et al. Mechanisms of miR-195-5p and FOXK1 in rat xenograft models of non-small cell lung cancer[J]. Am J Transl Res, 2021, 13(4):2528-2536.
|
21 |
Cao H, Chu X, Wang Z, et al. High FOXK1 expression correlates with poor outcomes in hepatocellular carcinoma and regulates stemness of hepatocellular carcinoma cells[J]. Life Sci, 2019, 228:128-134.
|